1月8日，佳禾智能盘中上涨2.05%，截至10:24，报17.92元/股，成交1.91亿元，换手率2.90%，总市值 68.19亿元。 机构持仓方面，截止2025年9月30日，佳禾智能十大流通股东中，香港中央结算有限公司位居第四大流 通股东，持股220.17万股，相比上期增加141.01万股。 资金流向方面，主力资金净流入1365.84万元，特大单买入1148.23万元，占比6.00%，卖出365.30万元， 占比1.91%；大单买入3401.10万元，占比17.77%，卖出2818.19万元，占比14.72%。 责任编辑：小浪快报 佳禾智能今年以来股价涨9.87%，近5个交易日涨11.58%，近20日涨4.98%，近60日涨8.54%。 截至9月30日，佳禾智能股东户数4.75万，较上期减少9.05%；人均流通股7828股，较上期增加9.95%。 2025年1月-9月，佳禾智能实现营业收入16.25亿元，同比减少15.91%；归母净利润2882.52万元，同比减 少60.03%。 分红方面，佳禾智能A股上市后累计派现2.23亿元。近三年，累计派现1.46亿元。 资料显示，佳禾智能科技股份有限公司位于广东省东 ...

荣泰健康所属申万行业为：家用电器-其他家电Ⅱ-其他家电Ⅲ。所属概念板块包括：人脑工程（脑机接 口）、DeepSeek概念、Web3概念、阿里概念、跨境电商等。 1月8日，荣泰健康盘中上涨2.09%，截至10:21，报27.38元/股，成交3.19亿元，换手率5.82%，总市值 55.68亿元。 资金流向方面，主力资金净流出1293.18万元，特大单买入1261.43万元，占比3.96%，卖出1506.88万 元，占比4.73%；大单买入4995.23万元，占比15.66%，卖出6042.95万元，占比18.95%。 荣泰健康今年以来股价涨14.99%，近5个交易日涨16.81%，近20日涨16.36%，近60日跌11.85%。 资料显示，上海荣泰健康科技股份有限公司位于上海市青浦区徐泾镇高光路169弄6栋02，成立日期2002 年11月15日，上市日期2017年1月11日，公司主营业务涉及按摩器具的设计、研发、生产和销售。主营 业务收入构成为：按摩椅96.12%，按摩小电器2.59%，其他(补充)1.00%，体验式按摩服务0.29%。 截至9月30日，荣泰健康股东户数1.55万，较上期增加15.59%；人均流 ...

Core Viewpoint - Aidi Te's stock price has shown fluctuations with a recent decline, while the company has experienced overall growth in revenue and profit year-to-date. Group 1: Stock Performance - On January 8, Aidi Te's stock price decreased by 2.09%, reaching 47.78 yuan per share, with a trading volume of 23.93 million yuan and a turnover rate of 0.69%, resulting in a total market capitalization of 5.09 billion yuan [1] - Year-to-date, Aidi Te's stock price has increased by 8.10%, with a 7.03% rise over the last five trading days, 9.44% over the last 20 days, and 10.02% over the last 60 days [2] Group 2: Company Overview - Aidi Te (Qinhuangdao) Technology Co., Ltd. is located in Qinhuangdao, Hebei Province, established on March 15, 2007, and is set to be listed on June 26, 2024 [2] - The company's main business involves the independent research, production, and sales of internationally competitive zirconia ceramic blocks and other dental restoration materials, with revenue composition as follows: dental restoration materials 73.74%, dental digital equipment 19.80%, and other products and services 6.46% [2] - Aidi Te belongs to the Shenwan industry classification of pharmaceutical biology - medical devices - medical consumables, and is associated with concepts such as medical devices, Alibaba concept, small-cap, margin financing, and specialized and innovative [2] Group 3: Financial Performance - As of September 30, Aidi Te had 9,851 shareholders, an increase of 4.66% from the previous period, with an average of 7,310 circulating shares per person, a decrease of 4.46% [2] - For the period from January to September 2025, Aidi Te achieved operating revenue of 747 million yuan, a year-on-year increase of 16.44%, and a net profit attributable to the parent company of 142 million yuan, a year-on-year increase of 27.40% [2] Group 4: Dividend Information - Aidi Te has distributed a total of 49.48 million yuan in dividends since its A-share listing [3]

Group 1 - The core viewpoint of the article is that Kefu Medical (301087) has added the "Brain Engineering" concept due to its strategic investments in the brain-computer interface field, which includes both invasive and non-invasive technologies [1] - Kefu Medical's main business involves the research, production, sales, and service of home medical devices [1] Group 2 - The company reported a total revenue of 2.398 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 6.63% [1] - The net profit attributable to the parent company for the same period was 260 million yuan, up 3.3% year-on-year, while the net profit excluding non-recurring items was 222 million yuan, an increase of 1.46% [1] - In Q3 2025, the company achieved a quarterly revenue of 902 million yuan, a significant year-on-year increase of 30.72%, and a net profit of approximately 92.83 million yuan, up 38.68% year-on-year [1] - The company's debt ratio stands at 27.37%, with investment income of 18.18 million yuan and financial expenses of -3.77 million yuan, while maintaining a gross profit margin of 53.35% [1]

Core Viewpoint - DataPort's stock has shown a positive trend with a 6.84% increase year-to-date and a 2.10% rise on January 7, 2025, indicating strong market interest and potential growth in the data center services sector [1]. Group 1: Stock Performance - As of January 7, 2025, DataPort's stock price reached 32.51 CNY per share, with a trading volume of 7.07 billion CNY and a turnover rate of 3.08%, resulting in a total market capitalization of 233.54 billion CNY [1]. - Year-to-date, DataPort's stock has increased by 6.84%, with a 7.29% rise over the last five trading days, a 0.77% increase over the last 20 days, and a 4.43% decline over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, DataPort reported a revenue of 1.241 billion CNY, reflecting a year-on-year growth of 4.93%, and a net profit attributable to shareholders of 120 million CNY, which is a 14.05% increase compared to the previous year [2]. - Since its A-share listing, DataPort has distributed a total of 205 million CNY in dividends, with 109 million CNY distributed over the last three years [2]. Group 3: Shareholder Structure - As of September 30, 2025, DataPort had 160,500 shareholders, an increase of 39.45% from the previous period, with an average of 4,474 circulating shares per shareholder, down by 28.29% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third largest with 8.0945 million shares, an increase of 1.053 million shares from the previous period [2].

Core Viewpoint - Liyang Chip has shown a positive stock performance with a year-to-date increase of 8.86% and a recent uptick in trading activity, indicating potential investor interest and market confidence in the company's growth prospects [1][2]. Group 1: Stock Performance and Market Activity - As of January 7, Liyang Chip's stock price rose by 2.09% to 30.22 CNY per share, with a trading volume of 1.59 billion CNY and a turnover rate of 2.63%, resulting in a total market capitalization of 6.148 billion CNY [1]. - The net inflow of main funds was 2.5699 million CNY, with significant buying activity from large orders amounting to 39.6731 million CNY, representing 24.87% of total transactions [1]. - The stock has experienced a 4.64% increase over the last five trading days and a 1.75% increase over the last twenty days, while it has seen a decline of 7.10% over the past sixty days [1]. Group 2: Financial Performance - For the period from January to September 2025, Liyang Chip reported a revenue of 443 million CNY, reflecting a year-on-year growth of 23.11% [2]. - The company's net profit attributable to shareholders was 754,700 CNY, which represents a significant year-on-year increase of 106.19% [2]. Group 3: Business Overview - Liyang Chip, established on February 10, 2010, and listed on November 11, 2020, specializes in integrated circuit testing solutions, wafer testing services, and finished chip testing services [1]. - The revenue composition of the company includes finished chip testing at 58.15%, wafer testing at 35.08%, and other services at 4.39%, with wafer dicing contributing 2.37% [1]. - The company operates within the semiconductor industry, specifically in the integrated circuit packaging and testing sector, and is associated with various concepts such as computing power, blockchain, and small-cap stocks [1]. Group 4: Shareholder Information - As of September 30, Liyang Chip had 22,800 shareholders, an increase of 50.88% from the previous period, while the average number of circulating shares per shareholder decreased by 33.44% to 8,924 shares [2]. Group 5: Dividend Information - Since its A-share listing, Liyang Chip has distributed a total of 120 million CNY in dividends, with cumulative payouts over the last three years amounting to 2.00309 million CNY [3].

1月6日，依米康盘中下跌2.05%，截至10:43，报14.84元/股，成交1.23亿元，换手率2.20%，总市值65.37 亿元。 资金流向方面，主力资金净流出1491.49万元，特大单买入325.58万元，占比2.64%，卖出340.67万元， 占比2.76%；大单买入1669.87万元，占比13.55%，卖出3146.27万元，占比25.53%。 依米康今年以来股价涨1.44%，近5个交易日涨1.44%，近20日涨3.34%，近60日跌6.90%。 截至9月30日，依米康股东户数6.27万，较上期增加4.88%；人均流通股5958股，较上期减少4.65%。 2025年1月-9月，依米康实现营业收入10.64亿元，同比增长52.61%；归母净利润2764.72万元，同比增长 273.71%。 分红方面，依米康A股上市后累计派现5107.09万元。近三年，累计派现0.00元。 机构持仓方面，截止2025年9月30日，依米康十大流通股东中，香港中央结算有限公司位居第七大流通 股东，持股189.98万股，为新进股东。 责任编辑：小浪快报 资料显示，依米康科技集团股份有限公司位于四川省成都高新区科园南二路二号，成 ...

截至9月30日，阳光电源股东户数23.55万，较上期增加31.08%；人均流通股6748股，较上期减少 23.71%。2025年1月-9月，阳光电源实现营业收入664.02亿元，同比增长32.95%；归母净利润118.81亿 元，同比增长56.34%。 分红方面，阳光电源A股上市后累计派现68.57亿元。近三年，累计派现59.11亿元。 阳光电源今年以来股价涨2.47%，近5个交易日跌3.21%，近20日跌3.70%，近60日涨20.40%。 资料显示，阳光电源股份有限公司位于安徽省合肥市高新区习友路1699号,香港湾仔皇后大道东248号大 新金融中心40楼，成立日期2007年7月11日，上市日期2011年11月2日，公司主营业务涉及太阳能、风 能、储能、电动汽车等新能源电源设备的研发、生产、销售和服务。主营业务收入构成为：储能系统 40.89%，光伏逆变器等电力电子转换设备35.21%，新能源投资开发19.29%，其他2.86%，光伏电站发电 1.75%。 阳光电源所属申万行业为：电力设备-光伏设备-逆变器。所属概念板块包括：数字经济、阿里概念、云 计算、逆变器、电力物联网等。 1月6日，阳光电源盘中上涨2 ...

Core Viewpoint - Liyang Chip has shown a positive stock performance with a year-to-date increase of 7.20% and a recent uptick in trading activity, indicating potential investor interest in the semiconductor testing sector [1][2]. Financial Performance - For the period from January to September 2025, Liyang Chip reported a revenue of 443 million yuan, representing a year-on-year growth of 23.11% [2]. - The company's net profit attributable to shareholders reached 754,700 yuan, marking a significant year-on-year increase of 106.19% [2]. Shareholder Information - As of September 30, the number of shareholders for Liyang Chip increased to 22,800, up by 50.88% from the previous period [2]. - The average number of circulating shares per shareholder decreased to 8,924 shares, down by 33.44% [2]. Dividend Distribution - Since its A-share listing, Liyang Chip has distributed a total of 120 million yuan in dividends, with 2.003 million yuan distributed over the past three years [3]. Market Activity - On January 6, Liyang Chip's stock price rose by 2.06% to 29.76 yuan per share, with a trading volume of 62.96 million yuan and a turnover rate of 1.05% [1]. - The company's market capitalization stands at 6.055 billion yuan [1]. Business Overview - Liyang Chip, established on February 10, 2010, and listed on November 11, 2020, specializes in integrated circuit testing solutions, wafer testing services, and related support services [1]. - The revenue composition includes 58.15% from finished chip testing, 35.08% from wafer testing, 4.39% from other services, and 2.37% from wafer dicing [1]. Industry Classification - Liyang Chip is classified under the Shenwan industry category of Electronics - Semiconductors - Integrated Circuit Packaging and Testing, and is associated with concepts such as computing power, Alibaba, East Data West Computing, small-cap stocks, and blockchain [1].

1月5日，敏芯股份盘中上涨2.04%，截至10:09，报80.56元/股，成交5612.24万元，换手率1.25%，总市 值45.15亿元。 敏芯股份所属申万行业为：电子-半导体-模拟芯片设计。所属概念板块包括：智能家居、智能穿戴、阿 里概念、无线耳机、小盘等。 截至9月30日，敏芯股份股东户数9762.00，较上期增加34.56%；人均流通股5740股，较上期减少 25.64%。2025年1月-9月，敏芯股份实现营业收入4.64亿元，同比增长37.73%；归母净利润3654.57万 元，同比增长175.99%。 分红方面，敏芯股份A股上市后累计派现1674.34万元。近三年，累计派现0.00元。 责任编辑：小浪快报 机构持仓方面，截止2025年9月30日，敏芯股份十大流通股东中，信澳领先增长混合A（610001）位居 第七大流通股东，持股76.89万股，相比上期减少37.22万股。信澳先进智造股票型A（006257）位居第 八大流通股东，持股74.02万股，相比上期减少76.13万股。 资金流向方面，主力资金净流出170.13万元，特大单买入103.84万元，占比1.85%，卖出116.86万元，占 比2. ...